Menu
Home Explore People Places Arts History Plants & Animals Science Life & Culture Technology
On this page
ATC code C02
Therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System: Antihypertensives

ATC code C02 Antihypertensives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C02 is part of the anatomical group C Cardiovascular system.

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC02. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

We don't have any images related to ATC code C02 yet.
We don't have any YouTube videos related to ATC code C02 yet.
We don't have any PDF documents related to ATC code C02 yet.
We don't have any Books related to ATC code C02 yet.
We don't have any archived web articles related to ATC code C02 yet.

C02A Antiadrenergic agents, centrally acting

C02AA Rauvolfia alkaloids

C02AA01 Rescinnamine C02AA02 Reserpine C02AA03 Combinations of rauwolfia alkaloids C02AA04 Rauwolfia alkaloids, whole root C02AA05 Deserpidine C02AA06 Methoserpidine C02AA07 Bietaserpine C02AA52 Reserpine, combinations C02AA53 Combinations of rauwolfia alkaloids, combinations C02AA57 Bietaserpine, combinations

C02AB Methyldopa

C02AB01 Methyldopa (levorotatory) C02AB02 Methyldopa (racemic)

C02AC Imidazoline receptor agonists

C02AC01 Clonidine C02AC02 Guanfacine C02AC04 Tolonidine C02AC05 Moxonidine C02AC06 Rilmenidine

C02B Antiadrenergic agents, ganglion-blocking

C02BA Sulfonium derivatives

C02BA01 Trimetaphan

C02BB Secondary and tertiary amines

C02BB01 Mecamylamine

C02BC Bisquaternary ammonium compounds

C02C Antiadrenergic agents, peripherally acting

C02CA Alpha-adrenoreceptor antagonists

C02CA01 Prazosin C02CA02 Indoramin C02CA03 Trimazosin C02CA04 Doxazosin C02CA06 Urapidil

C02CC Guanidine derivatives

C02CC01 Betanidine C02CC02 Guanethidine C02CC03 Guanoxan C02CC04 Debrisoquine C02CC05 Guanoclor C02CC06 Guanazodine C02CC07 Guanoxabenz

C02D Arteriolar smooth muscle, agents acting on

C02DA Thiazide derivatives

C02DA01 Diazoxide

C02DB Hydrazinophthalazine derivatives

C02DB01 Dihydralazine C02DB02 Hydralazine C02DB03 Endralazine C02DB04 Cadralazine

C02DC Pyrimidine derivatives

C02DC01 Minoxidil

C02DD Nitroferricyanide derivatives

C02DD01 Nitroprusside

C02DG Guanidine derivatives

C02DG01 Pinacidil

C02K Other antihypertensives

C02KA Alkaloids, excluding rauwolfia

C02KA01 Veratrum

C02KB Tyrosine hydroxylase inhibitors

C02KB01 Metirosine

C02KC MAO inhibitors

C02KC01 Pargyline

C02KD Serotonin antagonists

C02KD01 Ketanserin

C02KN Other antihypertensives

C02KN01 Aprocitentan

C02KX Antihypertensives for pulmonary arterial hypertension

C02KX01 Bosentan C02KX02 Ambrisentan C02KX03 Sitaxentan C02KX04 Macitentan C02KX05 Riociguat C02KX06 Sotatercept C02KX52 Ambrisentan and tadalafil C02KX54 Macitentan and tadalafil

C02L Antihypertensives and diuretics in combination

C02LA Rauwolfia alkaloids and diuretics in combination

C02LA01 Reserpine and diuretics C02LA02 Rescinnamine and diuretics C02LA03 Deserpidine and diuretics C02LA04 Methoserpidine and diuretics C02LA07 Bietaserpine and diuretics C02LA08 Rauwolfia alkaloids, whole root and diuretics C02LA09 Syrosingopine and diuretics C02LA50 Combinations of rauwolfia alkaloids and diuretics including other combinations C02LA51 Reserpine and diuretics, combinations with other drugs C02LA52 Rescinnamine and diuretics, combinations with other drugs C02LA71 Reserpine and diuretics, combinations with psycholeptics

C02LB Methyldopa and diuretics in combination

C02LB01 Methyldopa (levorotatory) and diuretics

C02LC Imidazoline receptor agonists in combination with diuretics

C02LC01 Clonidine and diuretics C02LC05 Moxonidine and diuretics C02LC51 Clonidine and diuretics, combinations with other drugs

C02LE Alpha-adrenoreceptor antagonists and diuretics

C02LE01 Prazosin and diuretics

C02LF Guanidine derivatives and diuretics

C02LF01 Guanethidine and diuretics

C02LG Hydrazinophthalazine derivatives and diuretics

C02LG01 Dihydralazine and diuretics C02LG02 Hydralazine and diuretics C02LG03 Picodralazine and diuretics C02LG51 Dihydralazine and diuretics, combinations with other drugs C02LG73 Picodralazine and diuretics, combinations with psycholeptics

C02LK Alkaloids, excluding rauwolfia, in combination with diuretics

C02LK01 Veratrum and diuretics

C02LL MAO inhibitors and diuretics

C02LL01 Pargyline and diuretics

C02LN Serotonin antagonists and diuretics

C02LX Other antihypertensives and diuretics

C02LX01 Pinacidil and diuretics

C02N Combinations of antihypertensives in ATC-group C02

Empty group

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html ↩

  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022. /wiki/World_Health_Organization ↩

  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022. https://www.whocc.no/atc/structure_and_principles/ ↩

  4. "ATC/DDD Index 2022: code C02". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=C02 ↩

  5. "ATCvet Index 2022: code QC02". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/?code=C02 ↩